Evidence map›Paper›PMID 36553295›Full record

ArticleChildren (Basel, Switzerland)2022

Analysis of Therapeutic Decisions for Infantile Hemangiomas: A Prospective Study Comparing the Hemangioma Severity Scale with the Infantile Hemangioma Referral Score.

Tong Qiu, Kaiying Yang, Shiyi Dai, Siyuan Chen, Yi Ji

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tong QiuDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
Kaiying YangDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
Shiyi DaiDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.
Siyuan ChenPediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.
Yi JiDivision of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.ORCID 0000-0002-9289-9660
Sichuan University · CN

Funding

Med-X Center for Informatics Funding Project YGJC004National Natural Science Foundation of China 82273556the 1·3·5 Project for Disciplines of Excellence Clinical Research Incubation Project, West China Hospital of Sichuan University 2019HXFH056the 1·3·5 Project for Disciplines of Excellence Clinical Research Incubation Project, West China Hospital of Sichuan University 2020HXFH048the 1·3·5 Project for Disciplines of Excellence Clinical Research Incubation Project, West China Hospital of Sichuan University ZYJC21060the Key Project in the Science & Technology Program of Sichuan Province 2019YFS0322the Key Project in the Science & Technology Program of Sichuan Province 2022YFS0225the Key Project in the Science & Technology Program of Sichuan Province 2022YFS0233the Project of '0 to 1' of Sichuan University 2022SCUH0033
6 · The paper itself

Abstract

backgroundIn view of the high incidence of infantile hemangioma (IH) in infants and young children, a comprehensive and reasonable evaluation scale for referral is urgently needed. This study compared the influence of the Hemangioma Severity Scale (HSS) and the Infantile Hemangioma Referral Score (IHReS) on treatment decisions for infantile hemangioma patients.

objectiveWe aimed to establish a reliable and effective evaluation method for referral.

methodsThis was a prospective study to determine whether treatment was needed for IH patients after evaluation with the HSS and IHReS.

resultsA total of 266 consecutive referred IH patients were evaluated for the risk of IH, and the treatment rate was 80.8%. The area under the curve (AUC) of the subject receiver operating characteristic curve (ROC) of treatment decision making after referral by the HSS was 0.703 (95% CI: 0.634-0.772), and after referral by the IHReS was 0.892 (95% CI: 0.824-0.960). LIMITATIONS: This was a single-center study.

conclusionsFor decisions regarding the treatment of IH patients, the IHReS has a higher efficiency and sensitivity than the HSS. However, the specificity of the IHReS is lower than that of the HSS.

Indexed as

area under the curve (AUC)Fagan nomogramHemangioma Severity Scale (HSS)Infantile Hemangioma Referral Score (IHReS)receiver operating characteristic curve (ROC)referral

Identifiers

PMID36553295
PMCPMC9777170
OpenAlexW4310989175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.